Literature DB >> 12358137

Clustering and heritability of insulin resistance in Chinese and Japanese hypertensive families: a Stanford-Asian Pacific Program in Hypertension and Insulin Resistance sibling study.

Kwan-Dun Wu1, Chin-Fu Hsiao, Low-Tone Ho, Wayne Huey-Herng Sheu, Dee Pei, Lee-Ming Chuang, David Curb, Yii-Der Ida Chen, Hui-Ju Tsai, Victor J Dzau, David Cox, Tong-Yuan Tai.   

Abstract

The clustering between hypertension and other metabolic abnormalities related to insulin resistance syndrome (IRS) has been investigated in cross-sectional and prospective studies. Offspring studies have revealed that the clustering characteristics of IRS have familial components. However, it is not known whether the clustering also occurs in siblings (sibs) with different levels of blood pressure (BP). In addition, the genetic susceptibility accounting for the clustering in hypertensive families has not been determined. Siblings with Japanese or Chinese ancestry and having either similar BP levels (concordant sibs) or different BP levels (discordant sibs) were recruited. The delta method and variance component model were applied to analyze the differences in metabolic variables between hypertension (HTN) and low BP (LBP) sibs, and to compute the polygenic heritabilities for these metabolic variables and insulin sensitivity. After adjustment for age, gender and body mass index (BMI), HTN (n=393) sibs had higher levels of triglyceride (p < 0.0001), VLDL-cholesterol (p<0.0001), fasting insulin (p < 0.05), and homeostasis model assessment of insulin resistance (HOMAir) (p < 0.05) than LBP sibs (n = 389), but there were no differences in fasting glucose or high density lipoprotein (HDL)-cholesterol. The HTN sibs also had higher plasma glucose and insulin levels at 2 h after 75 g oral glucose loading (p<0.001 and p<0.01, respectively). The heritability estimates for fasting glucose, fasting insulin and HOMAir were 0.58, 0.43 and 0.46, respectively; for triglyceride, HDL-cholesterol, and BMI they were 0.60, 0.63 and 0.54, respectively. In hypertensive families, sibs with extreme levels of BP have significant differences in IRS-associated metabolic variables. The clustering characteristics and the significance of heritability estimation for these metabolic variables indicate that IRS is familial in nature and heritable in Chinese and Japanese hypertensive families.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12358137     DOI: 10.1291/hypres.25.529

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  19 in total

1.  Sex-specific genetic architecture of human fatness in Chinese: the SAPPHIRe Study.

Authors:  Y-F Chiu; L-M Chuang; H-Y Kao; K-C Shih; M-W Lin; W-J Lee; T Quertermous; J D Curb; I Chen; B L Rodriguez; C A Hsiung
Journal:  Hum Genet       Date:  2010-08-20       Impact factor: 4.132

2.  The effects of the renin-angiotensin-aldosterone system gene polymorphisms on insulin resistance in hypertensive families.

Authors:  Chin-Fu Hsiao; Wayne W H Sheu; Yi-Jen Hung; Ming-Wei Lin; David Curb; Koustubh Ranadex; Thomas Quertermous; Yue-Ming Chen; Ida Yi-Der Chen; Kwan-Dun Wu
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2012-03-14       Impact factor: 1.636

3.  Bivariate genome-wide scan for metabolic phenotypes in non-diabetic Chinese individuals from the Stanford, Asia and Pacific Program of Hypertension and Insulin Resistance Family Study.

Authors:  Y-F Chiu; L-M Chuang; H-Y Kao; L-T Ho; C-T Ting; Y-J Hung; Y-D Chen; T Donlon; J D Curb; T Quertermous; C A Hsiung
Journal:  Diabetologia       Date:  2007-06-20       Impact factor: 10.122

4.  Diagnosis of insulin resistance in hypertensive patients by the metabolic syndrome: AHA vs. IDF definitions.

Authors:  C-M Hwu; C A Hsiung; K-D Wu; W-J Lee; K-C Shih; J Grove; Y-D I Chen; B L Rodriguez; J D Curb
Journal:  Int J Clin Pract       Date:  2008-06-28       Impact factor: 2.503

5.  Heritabilities, apolipoprotein E, and effects of inbreeding on plasma lipids in a genetically isolated population: the Erasmus Rucphen Family Study.

Authors:  Aaron Isaacs; Fakhredin A Sayed-Tabatabaei; Yurii S Aulchenko; M Carola Zillikens; Eric J G Sijbrands; Anna F C Schut; Wim P F Rutten; Huibert A P Pols; Jacqueline C M Witteman; Ben A Oostra; Cornelia M van Duijn
Journal:  Eur J Epidemiol       Date:  2007-02-21       Impact factor: 8.082

6.  Comparative evaluation of whole body and hepatic insulin resistance using indices from oral glucose tolerance test in morbidly obese subjects with nonalcoholic Fatty liver disease.

Authors:  Kamran Qureshi; Ronald H Clements; Fahad Saeed; Gary A Abrams
Journal:  J Obes       Date:  2010-06-08

7.  Genetic and environmental influences on factors associated with cardiovascular disease and the metabolic syndrome.

Authors:  Sonya J Elder; Alice H Lichtenstein; Anastassios G Pittas; Susan B Roberts; Paul J Fuss; Andrew S Greenberg; Megan A McCrory; Thomas J Bouchard; Edward Saltzman; Michael C Neale
Journal:  J Lipid Res       Date:  2009-04-16       Impact factor: 5.922

8.  Absence of evidence for an association between resistin gene variants and insulin resistance in an Asian population with low and high blood pressure.

Authors:  Jennifer L Kimbell; Tanya A Koropatnick; John S Grove; Yung-Hsiang Huang; Fu-Tien Chiang; Thomas Quertermous; Randi Chen; Timothy A Donlon; Beatriz L Rodriguez; J David Curb
Journal:  Diabetes Res Clin Pract       Date:  2008-05-22       Impact factor: 5.602

9.  Quantitative trait loci associated with blood pressure of metabolic syndrome in the progeny of NZO/HILtJxC3H/HeJ intercrosses.

Authors:  Eri Nishihara; Shirng-Wern Tsaih; Chieko Tsukahara; Sarah Langley; Susan Sheehan; Keith DiPetrillo; Satoshi Kunita; Ken-ichi Yagami; Gary A Churchill; Beverly Paigen; Fumihiro Sugiyama
Journal:  Mamm Genome       Date:  2007-07-20       Impact factor: 2.957

Review 10.  Are there genetic paths common to obesity, cardiovascular disease outcomes, and cardiovascular risk factors?

Authors:  Tuomo Rankinen; Mark A Sarzynski; Sujoy Ghosh; Claude Bouchard
Journal:  Circ Res       Date:  2015-02-27       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.